FR1499M - Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine. - Google Patents

Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine.

Info

Publication number
FR1499M
FR1499M FR869629A FR869629A FR1499M FR 1499 M FR1499 M FR 1499M FR 869629 A FR869629 A FR 869629A FR 869629 A FR869629 A FR 869629A FR 1499 M FR1499 M FR 1499M
Authority
FR
France
Prior art keywords
reserpine
hydrazino
pyridazine
carbamoyl
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR869629A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chimie et Atomistique SA
Original Assignee
Chimie et Atomistique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chimie et Atomistique SA filed Critical Chimie et Atomistique SA
Priority to FR869629A priority Critical patent/FR1499M/en
Priority to GB27572/62A priority patent/GB942981A/en
Application granted granted Critical
Publication of FR1499M publication Critical patent/FR1499M/en
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR869629A 1961-07-31 1961-07-31 Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine. Active FR1499M (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR869629A FR1499M (en) 1961-07-31 1961-07-31 Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine.
GB27572/62A GB942981A (en) 1961-07-31 1962-07-18 Therapeutic composition having a hypotensive action and containing a mixture of 3-hydrazino 6-carbamoyl pyridazine and reserpine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR869629A FR1499M (en) 1961-07-31 1961-07-31 Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine.

Publications (1)

Publication Number Publication Date
FR1499M true FR1499M (en) 1962-09-24

Family

ID=8760455

Family Applications (1)

Application Number Title Priority Date Filing Date
FR869629A Active FR1499M (en) 1961-07-31 1961-07-31 Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine.

Country Status (2)

Country Link
FR (1) FR1499M (en)
GB (1) GB942981A (en)

Also Published As

Publication number Publication date
GB942981A (en) 1963-11-27

Similar Documents

Publication Publication Date Title
FR1038M (en) Aspirin-based medicine.
FR3464M (en) Drug acting on the central nervous system based on azaspirans.
FR2012M (en) Medicinal product based on a new heptapeptide.
FR3405M (en) Medicinal product based on a sulfomethyl-polymyxin.
FR1374M (en) Diuretic drug based on a benzo-thiadiazine derivative.
FR1891M (en) Medicinal product based on a phenoxy-alkane.
FR1827M (en) Drug based on 1.5-benzo-dioxepannes.
FR2239M (en) Medicines based on dialkyl-aminoalkyl-piperidines.
FR1499M (en) Hypotensive drug based on the combination hydrazino-3-carbamoyl-6-pyridazine-reserpine.
FR2410M (en) Medicinal product based on oxazine derivative.
FR2297M (en) Amino acid-based hypotensive drug.
FR2231M (en) Drug based on new dibenzothiephinnes.
FR2415M (en) Drug based on substituted ethanolamines.
FR2238M (en) Hypotensive drug based on the combination of hydrazino-3 carbamoyl-6 pyridazine-pentamethyl-1,2,2,6,6, piperidine.
FR3323M (en) Medicinal product based on aza-thiaxanthene derivative.
FR2992M (en) Drug based on 2.4-diamino-6-hydroxymethyl-7.8-dihydro-pteridine.
FR2359M (en) Hecogenin-based antiphlogistic drug.
FR2577M (en) Drug based on naphthyl-amino-imidazoline.
FR2093M (en) Medicinal product based on a hydroxy-dibenzocycloheptane derivative.
FR1014M (en) Medicinal compositions based on 6-aryl-2,4,7-triaminopteridine.
FR1299M (en) Anorectic drug based on α, α-dimethyl-p-chlorophenyl-ethylamine.
FR1987M (en) Antilipemic drug based on modified heparin.
FR1327M (en) Bacteriostatic drug based on a sulfanilamido-pyrazole.
FR1345M (en) Drug based on imino-dibenzyl derivative.
FR2993M (en) Drug based on 2.4-diamino-6-hydroxy-7.8-dihydro-pteridine.